What's happening
This bill requires health insurance policies in New York to provide comprehensive coverage for obesity treatment, including medications, counseling, surgery, and wellness programs.
Why it matters
Limits insurer restrictions. The bill prohibits insurance companies from imposing coverage criteria for anti-obesity medications that are more restrictive than what the FDA requires, making it harder for insurers to deny access based on non-medical grounds.
Protects against financial discrimination. The legislation mandates that coverage for obesity treatment cannot carry higher deductibles, copays, or different annual/lifetime limits compared to coverage for other illnesses, ensuring equitable financial treatment for patients seeking obesity care.
Requires clear communication to patients. Insurers and Medicaid must provide prominent, written notice to all eligible members about the new obesity treatment coverage, which helps ensure that patients are aware of their rights and benefits.
Allows for appropriate medical review, but with safeguards. While insurers can still use utilization management (like reviewing medical necessity), they must apply the same standards as they do for other conditions, which helps prevent discriminatory or arbitrary denial of obesity treatments.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Cover Obesity Treatment Fully
Plain English, a few words. Used as the page title.
Sponsors
History
- Referred to insurance
- Referred to insurance
Full text
3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
8045
2023-2024 Regular Sessions
IN ASSEMBLY
September 13, 2023
Introduced by M. of A. REYES -- read once and referred to the Committee on Insurance
AN ACT to amend the social services law and the insurance law, in relation to requiring comprehensive coverage for treatment of obesity
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 2 of section 365-a of the social services law is amended by adding a new paragraph (mm) to read as follows:
(mm) (i) Comprehensive coverage for treatment of obesity, which shall include coverage for prevention and wellness, nutrition counseling, intensive behavioral therapy, bariatric surgery, and FDA-approved antiobesity medication. For purposes of this paragraph, "FDA-approved antiobesity medication" shall mean any medication approved by the federal food and drug administration with an indication for chronic weight management in patients with obesity.
(ii) Coverage criteria for FDA-approved anti-obesity medications provided under this paragraph shall not be more restrictive than the FDA-approved indications for such treatments.
(iii) Coverage under this paragraph shall be neither different nor separate from coverage for any other illness, condition, or disorder for purposes of determining deductibles, lifetime dollar limits, copayment and coinsurance factors, and benefit year maximum for deductibles and copayment and coinsurance factors.
(iv) Nothing shall preclude the undertaking of utilization management to determine the medical necessity for treatment of obesity under this paragraph, provided that all such appropriateness and medical necessity determinations are made in the same manner as those determinations are made for the treatment of any other illness, condition, or disorder covered by such policy, contract, or plan.
(v) The department shall provide notice to eligible persons regarding the coverage required by this paragraph. The notice shall be in writing
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD11933-01-3
and shall be prominently positioned in any literature or correspondence sent to members and shall be transmitted to members within the calendar year when annual information is made available to eligible persons, or in any other mailing or communication to eligible persons.
§ 2. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 39 to read as follows:
(39) (A) Every policy which provides medical, major medical, or similar comprehensive-type coverage shall provide comprehensive coverage for treatment of obesity, which shall include coverage for prevention and wellness, nutrition counseling, intensive behavioral therapy, bariatric surgery, and FDA-approved anti-obesity medication. For purposes of this paragraph, "FDA-approved anti-obesity medication" shall mean any medication approved by the federal food and drug administration with an indication for chronic weight management in patients with obesity.
(B) Coverage criteria for FDA-approved anti-obesity medications provided under this paragraph shall not be more restrictive than the FDA-approved indications for those treatments.
(C) Coverage under this paragraph shall neither be different nor separate from coverage for any other illness, condition, or disorder for purposes of determining deductibles, lifetime dollar limits, copayment and coinsurance factors, and benefit year maximum for deductibles and copayment and coinsurance factors.
(D) Nothing shall preclude the undertaking of utilization management to determine the medical necessity for treatment of obesity under this paragraph, provided that all such appropriateness and medical necessity determinations are made in the same manner as those determinations are made for the treatment of any other illness, condition, or disorder covered by such policy, contract, or plan.
(E) The insurer shall provide notice to covered persons regarding the coverage required by this paragraph. The notice shall be in writing and shall be prominently positioned in any literature or correspondence sent to members and shall be transmitted to members within the calendar year when annual information is made available to covered persons, or in any other mailing or communication to covered persons.
§ 3. Subsection (l) of section 3221 of the insurance law is amended by adding a new paragraph 22 to read as follows:
(22) (A) Every insurer delivering a group or blanket policy for delivery in this state that provides medical, major medical, or similar comprehensive-type coverage shall provide comprehensive coverage for treatment of obesity, which shall include coverage for prevention and wellness, nutrition counseling, intensive behavioral therapy, bariatric surgery, and FDA-approved anti-obesity medication. For purposes of this paragraph, "FDA-approved anti-obesity medication" shall mean any medication approved by the federal food and drug administration with an indication for chronic weight management in patients with obesity.
(B) Coverage criteria for FDA-approved anti-obesity medications provided under this paragraph shall not be more restrictive than the FDA-approved indications for those treatments.
(C) Coverage under this paragraph shall neither be different nor separate from coverage for any other illness, condition, or disorder for purposes of determining deductibles, lifetime dollar limits, copayment and coinsurance factors, and benefit year maximum for deductibles and copayment and coinsurance factors.
(D) Nothing shall preclude the undertaking of utilization management to determine the medical necessity for treatment of obesity under this paragraph, provided that all such appropriateness and medical necessity determinations are made in the same manner as those determinations are made for the treatment of any other illness, condition, or disorder covered by such policy, contract, or plan.
(E) The insurer shall provide notice to covered persons regarding the coverage required by this paragraph. The notice shall be in writing and shall be prominently positioned in any literature or correspondence sent to members and shall be transmitted to members within the calendar year when annual information is made available to covered persons, or in any other mailing or communication to covered persons.
§ 4. Section 4303 of the insurance law is amended by adding a new subsection (vv) to read as follows:
(vv) (1) Every policy which provides medical, major medical, or similar comprehensive-type coverage shall provide comprehensive coverage for treatment of obesity, which shall include coverage for prevention and wellness, nutrition counseling, intensive behavioral therapy, bariatric surgery, and FDA-approved anti-obesity medication. For purposes of this subsection, "FDA-approved anti-obesity medication" shall mean any medication approved by the federal food and drug administration with an indication for chronic weight management in patients with obesity.
(2) Coverage criteria for FDA-approved anti-obesity medications provided under this subsection shall not be more restrictive than the FDA-approved indications for those treatments.
(3) Coverage under this subsection shall neither be different nor separate from coverage for any other illness, condition, or disorder for purposes of determining deductibles, lifetime dollar limits, copayment and coinsurance factors, and benefit year maximum for deductibles and copayment and coinsurance factors.
(4) Nothing shall preclude the undertaking of utilization management to determine the medical necessity for treatment of obesity under this subsection, provided that all such appropriateness and medical necessity determinations are made in the same manner as those determinations are made for the treatment of any other illness, condition, or disorder covered by such policy, contract, or plan.
(5) The insurer shall provide notice to covered persons regarding the coverage required by this subsection. The notice shall be in writing and shall be prominently positioned in any literature or correspondence sent to members and shall be transmitted to members within the calendar year when annual information is made available to covered persons, or in any other mailing or communication to covered persons.
§ 5. This act shall take effect on the one hundred eightieth day after it shall have become a law and shall apply to any policy issued, delivered, renewed, and/or modified on or after the effective date of this act.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.